Suppr超能文献

心血管病生物标志物的开发:回顾过去,展望未来。

Biomarker Development in Cardiology: Reviewing the Past to Inform the Future.

机构信息

Cardiovascular Discovery Group, Kolling Institute of Medical Research, University of Sydney, St Leonards 2065, Australia.

Department of Cardiology, Royal North Shore Hospital, St Leonards 2065, Australia.

出版信息

Cells. 2022 Feb 8;11(3):588. doi: 10.3390/cells11030588.

Abstract

Cardiac biomarkers have become pivotal to the clinical practice of cardiology, but there remains much to discover that could benefit cardiology patients. We review the discovery of key protein biomarkers in the fields of acute coronary syndrome, heart failure, and atherosclerosis, giving an overview of the populations they were studied in and the statistics that were used to validate them. We review statistical approaches that are currently in use to assess new biomarkers and overview a framework for biomarker discovery and evaluation that could be incorporated into clinical trials to evaluate cardiovascular outcomes in the future.

摘要

心脏生物标志物已成为心脏病学临床实践的关键,但仍有许多有待发现的内容可以使心脏病患者受益。我们回顾了在急性冠状动脉综合征、心力衰竭和动脉粥样硬化领域中关键蛋白生物标志物的发现,概述了研究这些标志物的人群以及用于验证这些标志物的统计学方法。我们还回顾了目前用于评估新生物标志物的统计方法,并概述了一个可以纳入临床试验的生物标志物发现和评估框架,以便未来评估心血管结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d6e/8834296/c26bb351c9d2/cells-11-00588-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验